Cargando…
1027. Vancomycin Use in Community-Acquired Pneumonia: Assessing Inappropriate Therapy
BACKGROUND: Current Infectious Disease Society of America guidelines recommend anti-methicillin-resistant Staphylococcus aureus(MRSA) agents for treatment of community-acquired pneumonia (CAP) only in specific high-risk patients. There are limited data on duration of vancomycin use that is appropria...
Autores principales: | Shan, Timothy, Gore, Sara J, McCracken, Caitlin M, Tallman, Gregory B, Holmer, Haley K, Bearden, David T, McGregor, Jessina C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811279/ http://dx.doi.org/10.1093/ofid/ofz360.891 |
Ejemplares similares
-
1034. Automating Assessments of Vancomycin Appropriateness
por: Holmer, Haley K, et al.
Publicado: (2019) -
162. Assessment of Beta-lactam Allergies as Rationale for Receipt of Vancomycin for Surgical Prophylaxis
por: Tucker, Kendall J, et al.
Publicado: (2020) -
General Perceptions and Knowledge of Antibiotic Resistance and Antibiotic Use Behavior: A Cross-Sectional Survey of US Adults
por: McCracken, Caitlin M., et al.
Publicado: (2023) -
232. Impact of Weekend Initiation of Vancomycin or Piperacillin/Tazobactam on Days of Therapy Received upon Hospital Admission
por: McGregor, Jessina C, et al.
Publicado: (2020) -
2058. Patient Satisfaction Not Impacted by Antibiotic Prescribing for Viral Upper Respiratory Infections
por: Ray, Michael J, et al.
Publicado: (2019)